Image from New Yorker magazine article entitled "Mary had Schizophrephia and then didn't"

Mary Had Schizophrenia—Then Suddenly She Didn’t

Mary was treated for cancer, the drugs also relieved her psychosis of twenty years. Her daughter Christine described her as a “psychological débutante.” Illustration by Emiliano Ponzi

By Rachel Aviv, Staff Writer for the New Yorker magazine. Published in print on July 28, 2025.

When Christine was nine years old, her mother, Mary, said, “Come here. Iwant to tell you a secret.” They sat on a brown couch in their living room,in Santa Ana, California. Mary, who was forty-three, said that a man she hadknown in medical school, a professor, was sending her messages about a plan totake her away and live in a mansion together. “I remember feeling really excited,because that fit with my sense of what should be happening,” Christine said. “Iwas really into ‘Harry Potter’ and the idea that, if you are part of the select, you cansee a bigger story happening out there.”

Mary leaned over and began separating strands of Christine’s hair, as if searchingfor lice. “Does he put listening devices in your hair?” Mary asked, about theprofessor. “Does he ever ask you to say things to me?”

Christine, the older of two sisters, said, “I believed everything she said until sheaccused me of something that I knew wasn’t true.” Mary had always been tenderand doting and practical, and, Christine said, “I just had this feeling in my bodythat she was not the same.”

Her sister, Angie, who is seven years younger, learned to follow their mother’sinstructions, whether or not they made sense. “I was taught the rules of herdelusions at the same time as I was taught other rules and norms about the world,”Angie said. She came to view her mother’s stories about the professor, and about

friends who were part of his mission, as akin to tales in the Bible. “It’s kind of like,O.K., some of these people are real, and some of these people aren’t real,” she said.

Christine was often cast in the role of the villain. Her mother would yell at her forpoisoning her pizza or hiding her keys or other menacing deeds, even as Christinetried to explain that she hadn’t done them. Sometimes Mary smacked her. (Marydoesn’t remember this.) Christine began to mistrust her own memory, too. “Mymom would accuse me of things, and then I’d be, like, Maybe I did do thesethings,” she said. In fifth grade, she asked Santa Claus for a polygraph machine. “Ijust had this baseline sense of: I could be doubted at any time.”

She felt that people might help her mother if she could just find the rightlanguage to describe her transformation. By high school, she was spending somuch time studying the Diagnostic and Statistical Manual of Mental Disorders thatshe texted a friend that she had actually “married the dsm-iv.” She explained thather mother suffered from the “fregoli delusion,” a belief that strangers weredisguised as doubles of people she knew. In her journal, Christine wrote, “Mymom has erotomanic delusion disorder with a splash of persecutory delusions.”She asked for help from teachers and a school counsellor, but, she said, the“message I got was, basically, Everybody has their shit, and you have to just dealwith it and keep getting good grades.” 

Angie has no memories of Mary before her psychosis, but Christine remembers her as a “magical, glowing figure.” Photograph courtesy the family

Mary, who was from India and had worked as a physician there for a decade,spoke so much about the professor that her husband, Chris, who worked at theCalifornia Department of Motor Vehicles, eventually found the professor’snumber and called him. “He said, ‘I am not in contact with her,’ ” Chris recalled.“ ‘I didn’t even know your wife came to America.’ ” At the professor’s suggestion,Chris scheduled an appointment for Mary with a psychiatrist. Christine sat in thewaiting room, hoping that this would be the beginning of getting back the motherof her early childhood, whom she remembered as a “magical, glowing figure.” Butwhen Mary finished the appointment she said that the psychiatrist thought shewas fine. Not long afterward, Mary kicked Chris out of the apartment andbarricaded the door with a desk and two heavy suitcases. Christine and Angieallotted extra time to get to school each morning so they could remove theobstacles.

Karl Jaspers, the German psychiatrist and philosopher, has described what he callsthe “delusional atmosphere,” a profound alteration in the way certain peopleexperience the world. “There is some change which envelops everything with asubtle, pervasive and strangely uncertain light,” he wrote. People in this statesearch for a story that explains why everything suddenly feels uncanny andominous. The “vagueness of content must be unbearable,” he wrote. “To reachsome definite idea at last is like being relieved from some enormous burden.”

Mary had landed on a story that overwrote the reality of her daughters’ lives, butthey also recognized in it a kind of emotional logic. Mary had been pressured tomarry Chris, in an arranged match, and, when they settled in America, he hadtraditional ideas about a woman’s role and restricted her freedom to pursue hercareer. Christine and Angie came to feel that their mother’s delusions—that herformer colleagues would free her from marriage and she’d be restored to her placein the medical community—were “a way of explaining how she ended up trappedin this position,” Christine said. “We theorized that psychosis was almost areasonable response.”

Christine moved to New York after high school, because her favorite book,“Underworld,” by Don DeLillo, was set there, and because it seemed like thecity where people went to escape their homes. She lived in the Bronx, near herfather’s brother, and got a job at Planet Hollywood. She wanted to be a novelist,and obsessively re-read “Underworld,” covering the pages with determinedannotations: “integrated dialogue”; “meta commentary”; “sensation of youngimmediacy.”

Angie and her mother would text Christine asking for groceries or pizza, and shewould order the food for them from across the country. Mary was still barricadingthe door. Chris slept in his car. (Eventually, he moved in with a girlfriend.)Christine worried that Angie, who was eleven, was growing up in a kind of folie àdeux, a delusional system that structures two lives. Angie said, of her mother, “Icould never figure out why she was doing these things to me, and I had this kindof emotional explanation: Other things are just more important to her. I’m onlythere as a vessel for the magical thinking.” After about a year, Christine arrangedfor her mother and Angie to move to New York, too. (Mary asked me to use onlyher middle name, to protect her privacy.)

Mary moved into an apartment in the Bronx, in the same building as her brother-in-law, and plastered the walls with tape, to prevent reality-TV shows fromrecording her and Angie through the cracks. Angie tried to bathe while hermother was asleep because Mary believed there was a camera in the showerhead,and had covered it with a sock. Angie felt as if she were living in a kind of urbanversion of “Grey Gardens,” a formative movie for her. The documentary chroniclesthe lives of a mother and daughter, relatives of Jacqueline Kennedy Onassis, wholive together for years, piles of trash accumulating around them, social conventionsbecoming remote.

After two years in New York, Mary seemed increasingly unable to care for herself,so Christine, who had enrolled at Columbia, called the city’s mobile crisis unit, ateam that assesses people in psychiatric distress. The crisis unit knocked on Mary’s

door, and, after a conversation in which she described receiving electrictransmissions through a filling in her tooth, she was admitted to Mount SinaiBeth Israel hospital, in Manhattan.

Psychiatrists there petitioned a judge for permission to hospitalize her for a monthand treat her with antipsychotics, over her objections. “I believe that she has nojudgment concerning the nature of her illness,” one of them wrote. On anevaluation form, another psychiatrist initially wrote that Mary had an “unspecifiedpsychotic disorder.” Then, perhaps uncomfortable with such a vague diagnosis, shecrossed out the phrase and wrote, “Schizophrenia.” Mary was fifty-five years old,and her symptoms had begun in her early forties, which is unusual forschizophrenia. Most people are diagnosed in their twenties or early thirties.

Christine moved into her mother’s apartment and filed a petition for joint custodyof Angie. Their father, who was living in California, did not contest the petition. “Imake breakfast in the morning,” Christine wrote in her journal, describing hernew routine with Angie. “I wash the dishes. I lock the door at night. I haveestablished, kicking and screaming, my own rightful place as an active agent in theuniverse.”

When Mary was released from the hospital, she stopped taking her medications.Neither she nor her daughters thought they had helped her. For about a third ofpeople with schizophrenia, antipsychotics do not work. “I wish my mother’sdelusions and paranoia were treatable,” Angie wrote, in a college-application essay.“However, she has lived with them for 12 years, and her institutionalization lastyear had no effect.”

Mary’s admission to Beth Israel was the beginning of a nine-year cycle inwhich she was sent to psychiatric hospitals for weeks at a time before beingreleased, unchanged. Mary said that each time she was admitted to a hospital thestaff“kept asking the same questions, and it never made anybody have a different

outlook on the situation. Everyone stayed with the same thing. It wasschizophrenia.”

After five hospital stays, including one in which the police led her to anambulance in handcuffs because she wouldn’t leave her apartment, Mary wastransferred to the Bronx Psychiatric Center, a state facility that provides long-termcare. She observed that when patients refused medications staffwould sometimescall security, and the patients would be injected with drugs, a prospect thatterrified her. “I would take the medication without any question, because I’m notrisking fighting with security,” she told me. “These people are very sensitive towhat they call ‘challenging authority.’ ” She spent her days dreading the momentwhen she’d be forced to swallow her pills.

Mary sometimes imagined that God had a reason for keeping her in the hospital,but, she said, “I did not even want to go there, because the reasoning mind makesyou feel very nervous and uncertain.” Her daily life became so narrow that shestopped noticing the weather. “They don’t remind you about the changing season—that spring is coming into summer or the winter is coming into spring,” shesaid. “You just pass the days as quickly as possible.”

Christine, who spoke to her mother every week, said that Mary never articulatedher sorrow at the time. “I would have wanted to engage on the level of ‘I’m sorryyou’re there, do you feel sad?’ And I’m sure she was having those emotions, but shewasn’t able to express them. It was always ‘I’m being attacked. I’m being held like aprisoner here.’ ” Christine felt that her mother was safer at the Bronx PsychiatricCenter than she would be anywhere else, but she felt guilty for hoping that Marywould stay there for the rest of her life.

Mary was discharged in September, 2023, after a year. A week later, shecollapsed in her bathroom and struggled to move. She was taken to ahospital in Brooklyn, where the doctors told her to stop taking antipsychotics,because they thought her condition may have been a side effect of the drugs. Thenthey discovered that she actually had lymphoma, a sometimes fatal form of cancer.

She began seven cycles of a treatment that combined chemotherapy withrituximab, a medication that targets antibodies involved in the body’s immuneresponse.

When Christine and Angie visited her at the hospital, Mary responded to theirquestions with one-word answers. Her face had a vacant expression. Christine andAngie thought she was dying. Mary did, too. She dreamed about being a child,playing with her sister and four brothers, in Kolkata, where she grew up. “I toldmyself, ‘This must be the end of it,’ ” Mary said.

Angie, who was now twenty-two and had recently graduated from Dartmouth,prepared in therapy for her mother’s death. She said, “I had multiple sessionswhere I was just crying about the fundamental things I wish she had given me,like ‘I wish she could have told me what was going on in her head,’ or ‘I wish shecould have told me she was sorry for what she did.’ ”

By Christmas, two months after beginning chemotherapy, Mary was moving alittle more freely, and she had begun to carry on conversations. Christine andAngie noticed that her personality seemed different: she was calm, outgoing, andpolite, and she often expressed gratitude. Angie texted Christine that Maryseemed peaceful, as if maybe she was “getting some post-life or death clarity?”

Christine, who was twenty-nine and had settled in London, having moved therefor a master’s degree in psychology, was struck by her mother’s ability to watch thenews and absorb the information on its own terms. For years, the television hadbeen a source of agitation; Mary had said that people were using her ideas andrepeating her lines.

One day, when Christine was visiting the hospital, Mary asked for a phone. “I sortof teased her, ‘Now you’re asking for a phone?’ ” Christine said. “I wasn’t reallymaking much of it, but then afterward I thought, Why has she asked for a phone?That’s quite unusual.” Mary already had a phone, but it was in storage becauseshe’d told Christine that it contained spyware.

Angie gave her a flip phone and, to be safe, covered the camera with a piece oftape. “She seemed fine using it, which was odd,” Angie said.

In May, a month after Mary finished chemotherapy, Christine and Angie asked apsychiatrist at the hospital to examine her. Christine said, “The psychiatrist was,like, ‘Why have you called me here? I don’t understand. She has no symptoms.’And we were, like, ‘Yeah, that’s the reason we’ve called you here.’ ”

Christine had the same feeling in her body that she’d had when her mother firstbecame ill—the sense that something at Mary’s core had changed. She tried to getthe doctors to grasp the scale of her mother’s recovery. By the summer, her cancerwas in remission. She hadn’t taken antipsychotics for months, and yet “herpsychotic symptoms are gone,” a doctor wrote. Christine told the doctors, “Shehad a twenty-year psychiatric history. Have you heard of this? Could any of hermedications have caused this?” She spoke with a neurologist at the hospital, but hedidn’t have an answer. Omid Heravi, one of Mary’s oncologists, didn’t understandwhat had happened, either. “Medicine is very specialized—we don’t get involved inother fields,” he said. He guessed only that one of the cancer drugs she’d beengiven had had collateral benefits. “In medicine, all side effects are not bad,” heoffered.

When a person recovers from an illness, it is usually seen as the end of the story.But becoming sane also causes a kind of narrative collapse, a confrontation with apersonal history that is no longer recognizable. Christine encouraged her mother’sfriends and siblings, whom she’d been estranged from for years, to get back intouch. She wanted to restore her mother’s sense of connection, but, she said, “I alsowanted them to be able to tell me—outside of my childhood memories—if this isthe person she used to be.”

For years, Christine’s friends had known little about her mother beyond the detailsof her mental illness. “Suddenly, I was, like, ‘Hey, my mom’s better now. Would youlike to call her up and talk to her?’ And that was a shocking concept for them,” shesaid. “I mean, there are a lot of people who wouldn’t necessarily be open tojumping on a call without planning, but my mom was now the type of person whois quite flexible and responsive and conversationally fluid.” Christine described heras a “psychological débutante.”

Angie, who was living in Queens and working at a firm where she analyzeddata on sexual violence, felt skeptical that their mother’s transformation wasreal. Christine said, “I felt like, If Mom can disappear, then she can come back.”

But Angie didn’t have memories of Mary from before the illness, and it felt to herlike she was being asked to believe that her mother had become a new person. “Itend to choose security over the process of discovery,” Angie told me. “I didn’thave a curiosity that felt worth the emotional risks.” Angie had always felt that, onsome level, her mother had “chosen her delusions” over her children. She didn’twant to experience that choice being made again.

Christine searched for medical papers that might explain her mother’s recoveryand allow Angie to believe in it. She read about each of the medications that hermother had taken and concluded that the key drug may have been rituximab, theimmunosuppressant. “I have a new working theory,” she texted Angie, in May,2024. “Theoretically her chemo could have incidentally cured” her.

Christine found a handful of recent case studies that documented drasticpsychiatric recoveries after people were treated with drugs that dampen immuneactivity. A 2017 study in Frontiers in Psychiatry described a woman with a twenty-five-year history of schizophrenia. She also had a skin disease, for which she wasgiven drugs that reduced inflammation and suppressed her immune response. Herdoctors noticed a pattern: when they treated her skin lesions, her psychosis wentaway. They hypothesized that the rash and the psychosis had been caused by asingle autoimmune disorder, and were cured by the same drugs. Another paper inFrontiers in Psychiatry described a man with “treatment-resistant schizophrenia”who developed leukemia. After a bone-marrow transplant, which reconstituted hisimmune system, he startled his doctors by suddenly becoming sane. Eight yearslater, the authors wrote, “the patient is very well and there are no residualpsychiatric symptoms.”

Christine also discovered a Washington Post article from 2023 about a womannamed April, who had fallen into a catatonic state at the age of twenty-one andbeen diagnosed with schizophrenia. Sander Markx, a professor of psychiatry atColumbia, first encountered April at a psychiatric hospital on Long Island whenhe was a medical student; twenty years later, he was dismayed to find her at the

same hospital, in the same condition. “She has not been outside for twenty years—out of sight,” he said, at a symposium at Weill Cornell’s medical school. He andhis colleagues gave her an extensive workup and found that she had lupus, anautoimmune disorder that, in rare cases, can induce inflammation in the brain,causing symptoms that are indistinguishable from those of schizophrenia. Afterundergoing immunosuppressive therapy, including rituximab, April emerged from,essentially, a “twenty-five-year-long coma, and was able to tell us everything,”Markx said. “We don’t have a script for this. We don’t see patients coming backfrom this condition.”

April’s case helped give momentum to the founding, in 2023, of the StavrosNiarchos Foundation (S.N.F.) Center for Precision Psychiatry and Mental Health,at Columbia, which is working to uncover biologically distinct subtypes of illnessthat have been obscured by the broad categories in the DSM. Christine sent an e-mail to Markx, a co-director of the S.N.F. Center, with a brief time line of hermother’s life. “Her psychiatric symptoms disappeared and have yet to resurfacemonths later,” she wrote. “But her current clinicians are stumped as to why it hashappened.” When Markx didn’t respond, Christine, who was visiting New York,decided that she and Angie should go to Columbia to introduce themselves inperson. Markx wasn’t in his office—he had just begun an ongoing medical leave—but they slipped a handwritten card in a pink envelope under his door and usedinter-campus mail to send cards to the other directors of the center. They tried tothink of this step, Angie said, as “the part in the documentary where the camerasgo all shaky and you get the sense that someone is about to break a hole in thecase.”

Emil Kraepelin, who developed psychiatry’s first modern diagnostic system, inthe eighteen-nineties, defined the disease we now know as schizophrenialargely in terms of its hopelessness. The diagnosis allowed hospital administratorsto separate patients with “periodic insanities” (like depression and bipolar disorder)from those who were believed to be incurable and belonged in asylums. Kraepelin

hoped that schizophrenia would eventually reveal itself to be a disease likeneurosyphilis, which was then responsible for a large portion of the cases ofinsanity in psychiatry wards. In 1913, scientists demonstrated that bacteria hadinfected the brains of these patients. “The diseases produced by syphilis are anobject lesson,” Kraepelin wrote, four years later. “It is logical to assume that weshall succeed in uncovering the causes of many other types of insanity that can beprevented—perhaps even cured—though at present we have not the slightestclue.”

Psychiatry and neurology were originally one medical discipline, but graduallyneurologists took responsibility for diseases like neurosyphilis and dementia, inwhich the pathology could be seen in an autopsied brain, and psychiatristshandled the illnesses that were left behind, their causes still a mystery.Schizophrenia, which affects roughly one per cent of the population, became thedisorder through which psychiatry worked out its identity, in part because itseemed to embody the mystery and intractability of madness, presenting basicquestions about what it means to have a self. “The history of modern psychiatry is,in fact, practically synonymous with the history of schizophrenia, thequintessential form of madness in our time,” the psychologist Louis Sass haswritten.

But psychiatrists struggled to pinpoint a single feature that unified the diagnosis.“The great question is what is this ‘something’ that underlies the symptoms,” KarlJaspers wrote, in 1963. Three decades later, the psychiatrist Ian Brockingtonwarned that the obsession with schizophrenia had stifled clinical curiosity.“Smaller, more homogeneous entities have been sucked in by the gravity of the bigidea, and annihilated,” he wrote. For decades, scientists have been searching in vainfor a biological marker that would confirm whether someone has schizophrenia.Last year, in a paper in Schizophrenia Research, seventeen international expertsconcluded that schizophrenia was defined by no single etiology, symptom, or

biological mechanism. “It is prudent to wonder if the construct around which weare organizing this information is fundamentally flawed,” the authors wrote.

Perhaps the most vivid disruption to the idea of schizophrenia as a monolithicconcept began in 2007, when Josep Dalmau, a neurologist at the University ofBarcelona, started publishing papers with his colleagues which described youngpatients with delusions, hallucinations, and sudden changes in their behavior, likeagitation and inappropriate giggling. Within days or weeks, they deteriorated,developing seizures, losing consciousness, or struggling to breathe. Dalmaudiscovered that they had a form of encephalitis, inflammation of the brain. Theirimmune systems had misidentified the NMDA receptor—a protein in the brainthat affects mood and memory—as foreign and produced antibodies that attackedit. When these patients were treated with immunotherapy, the majority of themrecovered completely, sometimes within a month.

Thomas Pollak, a neuropsychiatrist at King’s College London and the MaudsleyHospital, told me that treating patients with the condition was “revelatory anddisquieting, because some of them looked exactly like the people I’d been seeing inthe psychiatry ward. It was uncanny to see that a presumably totally differentpathway could lead to this.” Their illness, which was named anti-NMDA-receptorencephalitis, usually began in their early twenties, just as schizophrenia often does.The discovery of the illness put pressure on the artificial division betweenpsychiatry and neurology—the only two fields of medicine that focus on the sameorgan. “Many of the symptoms are shared, but we are using different words,”Pollak said.

In “Brain on Fire,” a memoir from 2012, the journalist Susannah Cahalan—thetwo hundred and seventeenth person in the world to be diagnosed with anti-NMDA-receptor encephalitis—describes how for a month, in which she swungbetween paranoid aggression and euphoria, some doctors treated her as if she werejust a difficult psychiatric patient who drank too much. “If it took so long for oneof the best hospitals in the world to get to this step,” she wrote, “how many other

people were going untreated, diagnosed with a mental illness or condemned to alife in a nursing home or a psychiatric ward?”

Since Dalmau’s discovery, scientists have identified more than twenty newantibodies linked to psychiatric symptoms. In 2020, in a paper in The LancetPsychiatry, some two dozen researchers proposed a new category of illness called“autoimmune psychosis,” which may look like a milder or incomplete form ofencephalitis, the illness never progressing beyond psychiatric symptoms.Christopher Bartley, the chief of a unit at the National Institute of Mental Healthwhich investigates the role of immune dysfunction in mental illness, said that thetwenty known antibodies may be a “drop in the bucket.” There could be countlesstargets in the brain that antibodies attack, some subset of which may alter people’sperceptions and behavior. “We have to have epistemic humility and accept thatthere are alternative models of disease,” Bartley said.

To find psychiatric patients who might benefit from immunotherapy, researchershave set up centers, roughly similar to the one at Columbia, at Baylor College ofMedicine, in Texas; King’s College London; Uppsala University, in Sweden; andthe University of Freiburg, in Germany, among other places. Some of the bestresearch into the phenomenon has been conducted in Germany, where it’s morecommon for patients in a first episode of psychosis to have lumbar punctures toaccess their spinal fluid, which can reveal the presence of antibodies. Bartleyestimates that between one and five per cent of people who have been diagnosedwith schizophrenia actually have an autoimmune condition—a figure he based onhis own lab’s research, which has not yet been published, and also on a Germanstudy of a thousand patients, the most extensive study of autoimmune psychosis sofar. “Even one per cent ends up being almost a million people in the world whoshould be treated with a different kind of medicine,” he said.

The pharmaceutical treatment for schizophrenia has not meaningfully changed inthree-quarters of a century. Many pharmaceutical companies have left the fieldentirely. To get approved for the market, a medicine that works for one

schizophrenic patient must have a reasonable chance of working for another. Butonly blunt instruments have been effective in treating an illness that takes suchvaried forms. Newer antipsychotics are more refined than earlier ones, with fewerside effects, but almost all of them work in the same broad way, alleviating somesymptoms, like hallucinations and delusions, but not other common ones, like lackof motivation and an inability to experience pleasure. Andrew Miller, the vice-chair for research in the psychiatry department at the Emory University School ofMedicine, said that the field is haunted by the early success of antipsychotics,which were discovered by serendipity, in the nineteen-fifties. “You get lulled intothis sense that, because the drugs are one-size-fits-all, the disease is also one-size-fits-all,” he said. “With autoimmune psychosis, it’s so clear that there is somethingdifferent. And then you start to say, ‘Hey, is it possible that there are other clear-cut mechanisms to pathology that we’re missing because we’re lumping everyonetogether and saying they all have the same illness?’ ”

The S.N.F. Center is embarking on a project, beginning this fall, to screen all the patients hospitalized in the New York State mental-health system for autoimmune, metabolic, and genetic disorders, to see if there are people whose symptoms can be traced to a distinct biological mechanism. “I’ve always been aware of the possibility that there are treatable causes for psychosis lurking in chronic long-term patients,” Joshua Gordon, the executive director of the New York State Psychiatric Institute and a former director of the N.I.M.H., told me. “But the notion that we could make this work practically—that we could test for it—has really only become apparent in the last few years.” The S.N.F. Center will do blood work for everyone in the state’s psychiatric institutions, offering follow- 

up testing, such as lumbar punctures, to those with unusual results. Gordon sai d that, if the S.N.F. Center identifies a few dozen patients who can be treate d effectively enough to leave the hospital, “we will be able to start answering the question of whether this is worth trying across the whole population of people with schizophrenia.” Psychiatry has a legacy of implementing drastic procedures, like lobotomies, that later come to seem like folly. But it also has a history of proffering psychologica l theories for illnesses that are not yet understood on a biological level. Severa l psychiatrists told me that they’d found themselves rereading the history of the discipline, wondering, for instance, if some of those patients of Emil Kraepelin’s whose symptoms helped define schizophrenia might actually have had encephalitis or autoimmune conditions—specifically, a subset he described as having “spasmodic phenomena in the musculature of the face” and an inability t o walk without falling. There were also questions about whether these diseases could explain a condition called “lethal catatonia,” which was frequently described as a manifestation of schizophrenia: these patients became extremely agitated, and then slipped into a stupor. In 1986, in a study that inadvertently revealed the dangers of conceptual inertia, the American Journal of Psychiatry reviewed nearly three hundred cases of lethal catatonia. Nearly all the patients in the study had been treated with antipsychotics, and more than half of them died.

After reading Christine’s description of her mother’s case, Steven Kushner, aco-director of the S.N.F. Center, arranged a meeting with her and Mary andAngie. Mary was living at a rehabilitation center in the Bronx while she regained her muscle strength. She was reluctant to meet another psychiatrist, she told me, but she felt she needed to “rise up to the level of my daughters’ studiousness.” In October, 2024, Kushner and three colleagues came to the rehabilitation center and spoke with Mary for three hours. “Her psychosis was gone,” Kushner said. “There was no other conclusion. There was no way that she could have the quality of the conversation that we had and willfully suppress psychotic symptoms.”

In the conversation, Mary recounted intimate details about her daughters’ pasts—what they would eat for breakfast, their arguments at recess—but she made noreference to the delusional beliefs that had dominated their lives. When Angietold the doctors that her mother had sometimes prevented her from going outside,even to do homework with classmates, Mary offered a practical explanation: therewas crime in the Bronx, and she worried about Angie’s safety. To explain why sheput a sock over the showerhead in her bathroom, she said that she’d hoped to filtersediment from the water. She seemed to have filled in gaps in her memory in away that was consistent with her current identity, as a sane person.

In 1911, the psychiatrist Eugen Bleuler described how schizophrenic patients arecapable of a kind of “double bookkeeping”: they may simultaneously live in two“disjoint” worlds, one grounded in shared reality, the other in private delusions.They might believe that they are the center of a conspiracy involving nearlyeveryone they see but also make small talk at a deli and remember to give thecorrect change. It’s as if the delusions occupy their own ontological category,sealed offfrom the logic used to move through the world. Now, when Mary recallsher decades of illness, it is as if she is accessing only the shared-reality side of theledger. When she talks about her time at the Bronx Psychiatric Center, hermemories sound like those of a person trapped in an environment where shedoesn’t belong. “Angie and I treat it as if she had two selves,” Christine said. “ButMom describes her self as continuous.”

The S.N.F. Center arranged for Mary to have a lumbar puncture, to see if she hadany antibodies associated with known neuropsychiatric conditions. During theprocedure, Kushner said, he could sense that Mary had once had a “fantasticprofessional identity: she was holding court, telling stories about the lumbarpunctures she used to perform, how many patients she used to see in a day.” Thetest came back negative. Kushner tried to recover a frozen sample of Mary’scerebral-spinal fluid from when she was ill—a test done on that fluid would havebeen more revealing—but the fluid had been discarded. He believed that the most

likely explanation was that she’d had a form of autoimmune psychosis for whichthe associated antibody has yet to be discovered. “I think the consensus is that weare probably only aware of the tip of the iceberg of different kinds of antibodiesthat can produce autoimmune diseases, and certainly that holds for autoimmunepsychosis,” he said.

Some people, when they recover from psychosis, understand that the strangeenemies who plagued them never actually existed. Others say that they are relievedtheir enemies stopped pursuing them, but do not disavow the reality of theexperience. “We don’t know what happens for someone who was in a psychosis fortwenty years and then they are—let’s call it ‘cured,’ ” Kushner told me. “And Ihesitate to use that word, because the idea that this word is ever used in psychiatryis so exceptional.” But, he said, “the treatment modified Mary’s biology such thatthe disease is basically gone.”

Kushner began meeting with Mary and her daughters every few weeks, in part tohelp monitor for possible signs of relapse. At the meetings, they mostly avoidedtalking about Mary’s delusions. When the subject came up, Mary was quiet, orresponded in a tangential way, changing the subject. “She has this extraordinarilypleasant way of disarming the situation,” Kushner told me. The thought of havingcaused her daughters suffering seemed too painful to allow into her consciousawareness. “There’s not an appointment that goes by where she doesn’t remark,spontaneously, that her daughters are doing well,” he said. “I don’t think that’s byaccident.”

Kushner did not believe that Mary’s memory gaps reflected cognitive impairment—on a neuropsychological exam, her memory was better than average—but healso didn’t believe that she was purposely not remembering. “To look back and say,basically, ‘Twenty years of my life were out of reality’—that would be afundamental blow to her identity as a physician and mom,” he said, a challenge to“one of our most primitive instincts, that we can discern what is real.” When Iexpressed concern about how to present the disparity in memories sensitively, he

told me, “I think that is the story. How do you reconcile with, and compensate for,all those missing years?”

When people emerge from chronic delusional states, the work of psychiatry isconsidered complete. They are largely left on their own, with two irreconcilableviews of reality. “We need to really start thinking about what happens the morningafter these disorders are treated,” Kushner said.

Christine wasn’t sure if she could call her mother “cured” simply because shelacked her previous symptoms. “She’s not fixated on things likecontamination and surveillance, but at no point has she said she’s left those beliefsbehind,” she said. Christine felt that it was taboo to talk to her mother about whoshe had once been. She suffered from the intrusive thought that if she confrontedher mother with destructive things she had done, Mary would somehow revertback to the patterns from that time and become psychotic again. “It is quite atraumatized-kid thing to say, but I sort of feel like, How greedy can you get? Don’tlook a gift horse in the mouth,” she told me.

Christine didn’t know how to have an ordinary conversation with her mother. Fortwenty years, Mary had been suspicious when Christine asked her questions abouther life. Christine now felt like an adopted child “meeting my biological mom forthe first time,” she said. She bought a book by an anthropologist called “TheEssential Questions: Interview Your Family to Uncover Stories and BridgeGenerations” to help guide their conversations. “It says, ‘Allow them to talk aboutwhat’s important,’ ” Christine said, reading from the book, during a visit to hermother’s rehabilitation center. “If no one has ever let you speak about yourself, itcan be hard,” Christine went on. “You have to kind of—”

“Think,” Mary said.

“Maybe practice—gain your voice,” Christine said.

Christine, who recorded the conversation, began with warmup questions: “Whenyou were a kid, what was your favorite activity?”

“Running,” Mary answered immediately.

“What did you like about running?”

“It makes you feel you have wings.”

“What is your favorite TV show?” Christine asked.

“ ‘Seinfeld.’ ”

“ ‘Seinfeld’!” Christine said. “What did you like about ‘Seinfeld’?”

“The absurdity.”

Every few weeks, they tackled a new theme outlined in the book: time, identity,body, belief, possessions, memory, fear. Initially, Mary answered in few words, buteventually she became much more expansive. During one session, she offered thather views on physical discipline had evolved: she no longer thought that smackingwas acceptable. Christine said, “Without relating it to me or Angie, she sort ofsaid, ‘That’s what we were taught when we were younger, but I don’t think that’sthe right way to raise a kid.’ ” Christine felt that her mother may have beenreflecting, obliquely, on what had happened in their home. “The ability to say, ‘I’vechanged my mind’ felt like as much as I could ask for,” Christine said.

For years, Christine had been documenting her life—keeping a journal, savingrecords, recording important conversations—to compensate for the fact that she,too, had blank periods in her memories, coinciding with traumatic events. Shewasn’t sure if her mother’s breaks in memory—what she and Angie called “themissing years”—were different from her own. Recently, she had come across aproverb: “The axe forgets, but the tree remembers.” She felt that maybe she andher mother had reached an impasse that was actually universal—children have

always formed their identities around blows that their parents don’t even realizethey inflicted.

Angie felt less accommodating: “I’m happy that my mom is normal now, that wecan have a deep connection and I can share my life with her. And, at the sametime, I want justice for the child who was hurt by that other mother.”

Mary’s sister, Nima, told me that before her illness Mary was “very enduring,very patient.” Mary’s recommendations from professors at medical schooldescribe her as “kind and sympathetic,” always “willing to shoulder any extrawork.” When she came out of her psychosis, Mary returned to this dutiful versionof herself. She and her husband, Chris, began speaking on the phone every day.Chris told me that he felt as if he were re-meeting the woman he had known inthe early years of their marriage. “How come I lived all these years of darkness,and she suddenly looks normal to me?” he said. “She gives me comfort. She givesme emotional support.”

He asked her to do things, like travel to India to resolve a family financial dispute,that Christine and Angie found inappropriate. They encouraged Mary not tocomply with the request. Mary had let go of her paranoia that everyone wastargeting her, but they wished she could retain a wariness about people who hadhurt her in the past. “Now that she’s better, you can see how the delusionsprotected her from people stepping on her boundaries—and she doesn’t have areplacement strategy,” Christine said.

Mary readily agreed to speak with me for this story, but she struggled to imaginethat she could be anything more than a marginal presence in it. For years, she haddescribed how people on TV were lifting ideas and plots from her life story. “Itwas like she was saying, ‘I’m important,’ ” Christine said. “ ‘I have value. I havethings to say.’ And now we’re saying, ‘You’re important. You have value. You havethings to say.’ And she can’t access that sense of deserving to be the maincharacter.”

When I first met Mary, on a Zoom call with her and Christine and Angie, I askedif I could read her psychiatric records. She said yes but warned that they would bevery boring, adding that she couldn’t remember any of her psychiatrists. “I left thememories long before I left the place,” she said. Christine suggested that weinterpret this as her mother’s gentle way of saying no.

A few weeks later, Christine told me, Mary found a pile of psychiatric records inher room: “She was, like, ‘I don’t want to see them anymore, so Rachel can havethem and can get rid of them.’ And I was, like, ‘Yes, Mom, but Rachel is ajournalist. She’s not just a professional shredder.’ ” She said that her momresponded, “I just don’t want to see them myself.”

Mary seemed to be working out her ambivalence about her memories through thispile of papers. After speaking on Zoom every week for two months, Mary and Imet at her rehabilitation center, along with Christine and Angie. Toward the endof our conversation, she stood up without explanation, walked to a cabinet,retrieved the psychiatric records, and gave them to me. “I felt like what happenedwas a miracle,” she told me. “If it will give anyone else confidence, I’ll go with it.”

There is almost no medical literature about the afterlife of madness, theexperience of letting go of what Jaspers called the “definite idea.”Autoimmune psychosis raises the possibility of a swift, full recovery—a trajectorynot typically seen in schizophrenia—and in doing so supplies a new category ofwitness: a person who can describe what it feels like to look back on a self that is,in some sense, defunct. And yet sanity does not mean that a person views the pastwithout defensiveness or distortion. (To see too clearly can lead to a different kindof insanity, depression.) One of Christine’s fears was that, in talking with hermother about what she and Angie had been through, she would “rob her of thehuman capacity for denial.”

During one of my visits to the rehabilitation center, I asked Mary if she’d like toknow how I was writing about her daughters’ memories of her illness, or if she’d

prefer not to listen to that part of the story. Christine and I sat in chairs, and Marysat on the edge of her bed, beside a wooden table on wheels that she used both foreating and as a desk. Mary quickly responded that she wanted to know what herchildren recalled. “I’ll go with that, because that way it will help me to remember,”she said.

“You remember things very differently, and it might be painful,” Christine said,gently. “Do you feel comfortable emotionally with that?”

“Yeah, go ahead!” Mary said. “I’ll remember like a mother. I won’t remember fromyour point of view.” She told her, “This is the best time for me to relate to thesememories and make amends.”

Christine shared her first memory of the illness: sitting on the couch as hermother told her that the professor from medical school was in love with her.

Mary sat straight up on the bed, holding her arms over her stomach, staringintently at Christine. She had the bearing of a diligent student determined to passa difficult test.

“You asked if they had ever put things in my hair so that”—

“Microphones,” Mary said quickly. “Microphones.” She said that the professor andhis friends kept urging her to leave her husband: “They said, ‘Don’t worry aboutthe in-laws and all—just move away and begin on your own.’ ” The friends weretrying to help, but they were also harassing her, and she had no one to confide in.“I felt like she was supposed to be there for me,” Mary said, gesturing towardChristine. “But she was talking on behalf of my friends.”

“You would think that I was repeating phrases that were said to me by otherpeople.”

“I remember that very well,” Mary said.

“As a kid, I found it very hurtful.”

“I never blamed you,” Mary said. “But my classmates—I trusted them so much.”

“I was not in contact with your classmates,” Christine said, in a measured tone. “Iwould explain that to you, but it felt like you didn’t believe me at that time.” Sheasked, “Now that I’m older, do you trust me when I say they weren’t talking tome?”

Mary said it was possible that Christine had been reading her e-mails, rather thantalking directly to the classmates, or that Christine’s father was the one tellingChristine what to say. “She was very articulate,” Mary said. “She would doeverything he would tell her.”

Mary explained that the feeling of being harassed—sometimes by people from herpast, sometimes by strangers—continued until several weeks after her cancerdiagnosis. “I felt like they were working through the doctors, and I had to take thechemotherapy just to hurt me and make me bald and make me lose weight andhumiliate me,” she said.

But then, a few weeks into her treatment, her dreams became uncharacteristicallypleasant. She kept dreaming of her sister and brothers, and they were so sensitiveand loving that she thought maybe this was the prelude to a kind of heavenlyafterlife. In time, the dreams began to feel more conscious, as if she were guidingthe scenes herself. Lying in her hospital bed, she tried to recall details about herchildhood home which she hadn’t thought about in years. “Whatever I could catchon to, I would collect,” she said.

Her reëmergence seemed to have occurred weeks before her daughters graspedwhat was happening. Her muscles were so weak that she couldn’t say more than aword at a time, and she wished she could communicate to her daughters, “I’msmiling. I’m all right with this.”

The thought that people were secretly trying to punish her hadn’t completelydisappeared, but it felt distant, a relic of a different era. When the thoughtresurfaced, she said, “I take myself out of it, and I say, ‘It’s not my burden.’ I putthe whole thing, like a gift basket, to God.” She’d been taught this copingmechanism as a schoolgirl, but until recently it hadn’t worked.

Christine felt both validated and disoriented by the idea that, between her andher mother, the facts were never really in question. “It is painful to hear thatshe still thinks I was spying on her all those years, but now she says, ‘I am so proudof my daughters—they take care of me,’ ” she said. “Maybe her interpretation isthat through the power of forgiveness she can now interact with me as her lovingdaughter. So can I make do with that?”

For a year, Christine and Angie had been speaking on Zoom with a familytherapist, to help process the changes in their mother. Recently, Mary had begunparticipating in the conversations, too. During a session, Christine suggested thatthe three of them begin a process of sharing grievances, each taking a turn. “Therewere different times when each of us was a flawed caretaker,” Christine said. Sheknew that her mother must have felt betrayed when she called the mobile crisisunit. Mary agreed: “I felt very let down because nobody trusted me enough toshare that information.” Christine began by telling her, “I did my best, and yet I’msorry I hurt you.”

Although Christine and Angie felt they had already worked out the conflicts intheir own relationship, they tried “performing a kind of play,” as Christine put it:they shared resentments—Angie’s feelings of abandonment, Christine’s sense thatAngie didn’t want her help—and then apologized, “so that at some point she cansay the words to us.” Each emphasized that she didn’t think the other was a badperson, and that it was O.K. that they remembered things differently. They triedany exonerating phrase they could think of, “in case these might be the mentalblocks for her,” Christine said.Rachel Aviv is a staff writer at The New Yorker. She is the author of “Strangers to Ourselves: Unsettled Minds and the Stories That Make Us,” a finalist for the 2022 National Book Mary was enthusiastic about the process, but Christine sensed that she didn’t quite know what to say when it was her turn. A lifelong student of her mother’s mind, Christine had several justifications for her mother’s failure to respond in kind: she had not grown up in a culture where regrets were aired in this way; the inability to see her daughter’s perspective was a lingering cognitive symptom; in her fragile state, apologizing required a level of confidence she didn’t yet have. “At this stage of my life, I need to feel like my mother is back,” Christine told me. Later on, maybe in a few years, she said, “I’ll deal with the fact that it was an imperfect mother who was returned to me.” ♦ An earlier version of this article misstated the Texas institution that houses a center similar to the one at Columbia. Published in the print edition of the July 28, 2025, issue, with the headline “Second Life.” Critics Circle Award.

PANDAS: A cute name for a terrible illness that claimed a beautiful life

By Shawne K. Wickham, Special to the Union Leader | Dec 20, 2024 

Alexandra “Alex” Manfull was bright and beautiful, clever and creative, with a promising future ahead of her. 

She was just 26 when she died, the victim of a mysterious illness that hijacked her brilliant mind and broke her parents’ hearts. 

In the six years since Alex’s death, her parents, Susan and Bill “Towny” Manfull of Portsmouth, have devoted themselves to spreading awareness of, and research into, Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus, commonly called PANDAS. 

Since the death of their daughter, Alex, from PANDAS, Susan and Towny Manfull have devoted themselves to spreading awareness of the illness and encouraging research. Photo credit: Shawne K. Wickham

“We don’t want this to happen to another person or family,” Towny Manfull said.

The cute acronym belies the terrible nature of the illness. PANDAS and a related disorder, Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), are characterized by sudden-onset psychiatric symptoms, notably obsessive-compulsive disorder, tics and anxiety, following an infection such as strep throat or scarlet fever.

The bacteria that causes such infections can hide in the body by mimicking other molecules. Eventually, the body recognizes them as foreign, triggering an immune response. But the immune system also attacks the body’s own tissues, and when that includes the brain, it can set off neuro-psychiatric symptoms. 

The disorder typically appears in childhood. But for Alex Manfull, it struck when she was in college. 

“Our daughter was the center of our lives,” said Susan Manfull, a social psychologist. “She was a real force. From the very beginning, she had a personality that really lit up the room.” 

As a child, Alex Manfull published a local newsletter in Portsmouth. Photo credit: Shawne K. Wickham

In elementary school, young Alex wrote and published a neighborhood newsletter, complete with local news and advertising. She won New Hampshire Public Television’s “Reading Rainbow” contest, and her story was animated and shown on television. She was interviewed by personality Don Imus on his radio show — twice. 

“She had an awesome sense of humor and this big laugh,” Susan Manfull said. “She really was a very happy child.” 

As Alex got older, her creativity only grew. A writer, artist and photographer, fluent in French, she attended Phillips Exeter Academy. The summer before college, she traveled to Jordan to study Arabic through a State Department program. 

She came home from Jordan with strep throat, and was treated with antibiotics. Her parents weren’t worried. 

Alex went on to Princeton University, where she was a coxswain on the crew team. In her sophomore year, she got mononucleosis and a second strep infection, and she seemed to be responding to the antibiotic treatment. 

“But it was shortly after that, she began exhibiting symptoms that no one, including us, recognized as anything other than stress in college,” Susan Manfull said. 

As a youngster, Alex Manfull was interviewed by radio personality Don Imus. Photo credit: Shawne K. Wickham

Beginning to understand 

PANDAS/PANS is a continuum. Symptoms ebb and flow; they can be mild and then become incapacitating in what are called “flares,” Susan Manfull said. 

And that’s what happened to Alex. 

She began developing anxiety, insomnia and skin problems. What she didn’t tell her parents until later was that she was having symptoms of obsessive compulsive disorder, including counting her steps. 

All this was affecting her schoolwork. She had trouble finishing long exams, and was late turning in papers. 

Her parents now know that PANDAS accounts for everything Alex was experiencing. 

“There’s a lot of symptoms that you have to connect the dots,” Towny Manfull said. “And today, very few clinicians have the skill or the experience to look at all these different symptoms and say, ‘Why did this start?’” 

Alex was diagnosed with OCD and prescribed anti-anxiety medication. She graduated from college and moved to New York City, working as a financial analyst. 

But her parents noticed changes in her personality. Their easy-going daughter easily became irritated. “She had a really short fuse. She was tired all the time because she didn’t sleep, but also she was working all those long hours,” her mother said. 

Then Alex went to work for a hedge fund where, as part of her research, she came across some information about PANDAS. 

Explanation at last 

She called her parents. “She said, ‘I think I know what I have,’” Susan Manfull said. “I still remember it so vividly but I also remember thinking: PANDAS? Really?” 

The name does a disservice, she now believes. Dartmouth Health, a leader in research and treatment, uses the term “neuro-immune psychiatric disorder,” and has established a clinic by that name, she said. 

Alex was elated to have an explanation for her diverse, debilitating symptoms, Susan Manfull said. When Alex moved to Washington, D.C., she made an appointment with a neurologist who was very knowledgable about PANDAS, and who told Alex she was certain that’s what she was dealing with. 

“Alex was thrilled, and she said, ‘When I get better, I’m going to tell everybody about this,’” she said. “We laughed about who was going to write the New Yorker article.”

The Manfulls had no idea how severe the illness can be, she said. “At the time there was just nothing in the literature about having these intrusive thoughts to take your life, or self-injurious types of behaviors.”

But one evening, Alex started texting Susan. She had been sick and had taken antibiotics, but she told her mom, “There’s something really wrong. This is really different.”

Susan promised to fly down the next day. She called Alex the next morning, but her daughter was upset and hung up on her, something she’d never done before. She tried to call Alex back, but there was no answer.

“I never talked to her again,” she said.

“We didn’t realize how unwell she was,” she said. “She ended up engaging in behaviors that took her life.”

They do not believe their daughter intended to harm herself. What makes them so sure?

“A lifetime of knowing this young woman,” Towny Manfull said. “This was not her. She was a fighter.”

“The day before this, she was looking forward to getting her treatment and changing the way people see this disorder.”

Acting on impulse

That morning, Alex had ordered a battery charger on Amazon and looked at a couch on Craig’s List. And a bag packed with equipment for a soccer league she had joined with work colleagues was sitting by the door. “So this was clearly something that came suddenly,” Towny Manfull said.

Susan Manfull displays a cherished keepsake, an illustrated story that her daughter Alex wrote in third grade that won New Hampshire Public Television’s “Reading Rainbow” contest. Photo credit: Shawne K. Wickham

Experts have since explained to the Manfulls that’s what can happen. “They have a flare and… they get these intrusive thoughts that tell them to take their lives,” Susan Manfull said. “They are so compelling that they can’t resist them and they act on them in an impulsive manner.”

“I’m positive that is what happened to her.”

They have talked with other parents with heartbreakingly similar stories. “There are young kids who end up dying because they listened to these intrusive thoughts,” Susan Manfull said. 

Parents say the symptoms of PANDAS/PANS come on suddenly. “They put their child to bed and their child woke up a different person,” she said. “Or they come home from school and they are a drastically different person.” 

The Manfulls have also talked with young people who have PANDAS. “Most of the time when they have these flares, they have no recollection of what happened,” Towny Manfull said. “It really is bypassing the executive level of the brain.” 

“I think that’s the scariest part of this,” he said. “As a parent, it’s your worst fear.” 

Alex’s legacy 

Their only child’s sudden death galvanzied them to action. “If this can happen with Alex Manfull, this can happen to anybody,” Susan said. 

They created the Alex Manfull Fund, which supports research into these disorders, produces a podcast and newsletter, and does legislative outreach. They sponsor symposiums for clinicians, researchers, advocates and policymakers to explore the latest treatment and diagnostic information. 

The theme of a symposium they hosted last month was “Dialogue Saves Lives.” It takes a multi-disciplinary team to properly identify and treat this illness, Susan Manfull said. 

One guest speaker, Dr. Richard Morse, a pediatric neurologist at Dartmouth Health Children’s, said the abrupt onset of OCD and tics is an important clue. “This is really lightning quick, over the course of a day, or two at the most,” he said. 

The illness can progress to include mood disorders, behavioral regression, deterioration of cognitive functioning and suicidal ideation, Morse said, so early diagnosis can make a huge difference. Otherwise, he said, “It may end in great despair and a loss of a life.” 

So much about these disorders remains a mystery, Towny Manfull said. “What we don’t know still today is why do some people get strep regularly and never have any adverse effect, and then other kids do have it,” he said. “So I think it’s still complicated, and we don’t have answers for that.”

And that’s why teaching medical and mental health providers to recognize the symptoms is so critical, his wife said. “If the infection and the immune system are not treated, you will continue to have this, and it will get worse and much more difficult to treat,” she said.

“Our vision is that no one else will ever lose their life, or lose years of their life … to find the right treatment,” she said.

At last month’s symposium, Susan Manfull invited the audience to “imagine a world without PANS and PANDAS.”

“I think that we will always have psychiatric symptoms, but imagine that we caught them early enough so that we diagnosed them early and they were treated effectively and resolved,” she said. “And the person with those symptoms can go back and live a healthy life.”

“We can do this,” Manfull said. “We can change the world. And we are here today to start that.”

A ‘Crazy’ Idea for Treating Autoimmune Diseases Might Actually Work

Sarah Zhang

Lupus has long been considered incurable—but a series of breakthroughs are fueling hope.

Illustration by The Atlantic. Sources: Jacopin / BSIP / Getty; Velimir Zeland / Shutterstock.

Lupus, doctors like to say, affects no two patients the same. The disease causes the immune system to go rogue in a way that can strike virtually any organ in the body, but when and where is maddeningly elusive. One patient might have lesions on the face, likened to wolf bites by the 13th-century physician who gave lupus its name. Another patient might have kidney failure. Another, fluid around the lungs. What doctors can say to every patient, though, is that they will have lupus for the rest of their life. The origins of autoimmune diseases like it are often mysterious, and an immune system that sees the body it inhabits as an enemy will never completely relax. Lupus cannot be cured. No autoimmune disease can be cured.

Two years ago, however, a study came out of Germany that rocked all of these assumptions. Five patients with uncontrolled lupus went into complete remission after undergoing a repurposed cancer treatment called CAR-T-cell therapy, which largely wiped out their rogue immune cells. The first treated patient has had no symptoms for almost four years now. “We never dared to think about the cure for our disease,” says Anca Askanase, a rheumatologist at Columbia University’s medical center who specializes in lupus. But these stunning results—remission in every patient—have fueled a new wave of optimism. More than 40 people with lupus worldwide have now undergone CAR-T-cell therapy, and most have gone into drug-free remission. It is too early to declare any of these patients cured for life, but that now seems within the realm of possibility.

Beyond lupus, doctors hope CAR-T portends a bigger breakthrough against autoimmune diseases, whose prevalence has been on a troubling rise. CAR-T has already been used experimentally to treat patients with other autoimmune diseases, including multiple sclerosis, myositis, and myasthenia gravis. And the success of CAR-T has inspired researchers to borrow other—cheaper and simpler—strategies from cancer therapy to kill immune cells gone awry. Not all of these ideas will pan out, but if any do, the next few years could bring an inflection point in treating some of the most frustrating and intractable diseases of our modern era.

CAR-T-cell therapy was originally developed as a way to kill malignant cells in blood cancer. It could, scientists later reasoned, also be used to kill specific white blood cells, called B cells, that go haywire with certain autoimmune diseases. One group tried a CAR-T-like therapy against an autoimmune disease called pemphigus vulgaris, and another CAR-T against lupus. It worked—but these experiments were only in mice.

This was the sum total of available scientific evidence when a 20-year-old woman came to her doctors in Erlangen, Germany, asking to try anything for her severe and uncontrolled lupus. None of the long-term medications typically used to manage lupus were working. Her kidneys, heart, and lungs were all failing, and she could walk only 30 feet by herself. CAR-T was risky, her doctor agreed, but lupus was killing her.

CAR-T-cell therapy could essentially turn her immune system against itself. First, doctors extracted from her blood a class of immune cells, called T cells, which they then engineered into chimeric antigen receptor T (CAR-T) cells that could recognize and destroy the B cells driving her lupus. CAR-T cells can cause dangerous and overwhelming inflammatory responses in cancer patients, and her doctors did worry that CAR-T could do the same for someone with autoimmune disease, whose immune system is already in overdrive. “We take the T cells out, activate them like crazy, and then shoot those massively overactivated T cells in an activated autoimmune disease. So if you think about it, that’s kind of crazy to do that, right?” says Fabian Müller, a hematologist-oncologist at the University Hospital of Erlangen and one of the doctors on the German team that pioneered the treatment. But fortunately, the woman with lupus did not have any serious side effects, nor did any of the other patients the German group has since dosed. They are all living their everyday lives, free of lupus symptoms and medications. The woman who could walk a mere 30 feet now runs five times a week, Müller told me. She’s gone back to school and is considering studying for a master’s in immunology.

Müller and his colleagues believe that CAR-T-cell therapy works by wiping out enough B cells to trigger a “deep reset” of the immune system. CAR-T cells are dogged little assassins; they are able to find and destroy even the B cells hiding deep in the body’s tissues. A patient’s B-cell count eventually recovers, but the new ones no longer erroneously attack the body itself. Cancer patients are sometimes considered “cured” after five years of remission, and the first lupus patient to receive CAR-T is not so far off from that milestone. But the therapy cannot erase the genetic predisposition many patients have for the disease, says Donald Thomas, a rheumatologist in Maryland. Whether remission is actually durable enough to be a “cure” will take time to find out.

Still, these extraordinary results have set off a gold rush among biotech companies eager to solve autoimmune diseases. CAR-T start-ups founded to treat cancer are pivoting to target autoimmune diseases. And large pharmaceutical companies such as Bristol Myers Squibb, AstraZeneca, and Novartis are developing their own therapies. Columbia’s Askanase is now an investigator on five separate trials, all using CAR-T or a similar cellular therapy, and she hears from more companies all the time. There’s so much interest, she told me, “I don’t even know there are enough patients” to test new treatments. About 1.5 million Americans have lupus, but only a minority of them—those sick enough to justify experimental treatment but not so sick that they’ve suffered too much irreversible organ damage—are eligible for trials.

For now, CAR-T for lupus and other autoimmune diseases is pretty much only accessible in the U.S. through clinical trials—which, in effect, means it’s inaccessible to almost all lupus patients. Jonathan Greer, a rheumatologist in Florida, works in a seven-doctor practice that treats hundreds of people with lupus; not a single one has received CAR-T. He doesn’t know of a single center in Florida that is up and running to do these studies, so interested patients would have to travel out of state.

Even if it becomes FDA approved for autoimmune diseases, CAR-T is a long and expensive process. Because each patient’s own cells are reengineered, it cannot be easily scaled up. The cost of CAR-T for cancer runs about $500,000. Patients also need chemotherapy to kill existing T cells to make room for CAR- T, which adds risk, and in lupus, they usually need to taper off any medications keeping their disease in check, which can cause flare-ups. All these complications make the current iteration of CAR-T suitable only for lupus patients with severe disease, who have run out of other options.

The practical limitations of CAR-T have dogged the cancer field for a long time now, and researchers have already come up with ideas to get around it. A number of simpler strategies for killing B cells are now making their way from blood cancer to autoimmune disease. They include using donor T cells, a different type of immune cell called natural killer cells, or a molecule that binds a T cell to the B cell it’s meant to destroy. Those molecules, called bispecific T-cell engagers, or BiTEs, are “cheap, fast, uncomplicated,” Müller said, but they may not penetrate as deeply into the tissues where B cells reside. Nevertheless, in September, The New England Journal of Medicine published two successful case reports describing successful treatment in a handful of autoimmune diseases, including lupus, with a BiTE called teclistamab. Similar BiTES on the market could be repurposed for autoimmune disease too.

These simpler therapies may ultimately be “good enough,” Askanase said. And their ease of use could ultimately beat out custom CAR-T therapy, which is unlikely to reach all of the millions of people with lupus worldwide. It’s simply too expensive and too cumbersome, a problem that has held back other cutting-edge therapies that were approved to much initial fanfare. Even if CAR-T itself is never widely adopted for autoimmune diseases, it has opened the door to new ideas that could one day revolutionize their treatment.

GUMC Announces New PANDAS/PANS Fellowship

The Hoya • October 26, 2024 • https://thehoya.com/news/gumc-announces-new-pandas-pans-fellowship/

By Pritika Patel, Special to The Hoya

The Georgetown University Medical Center, in collaboration with the Alex Manfull Fund, which funds research on postinfection neuroimmune disorders, announced the launch of the new PANDAS/PANS Fellowship Fund Oct. 9.

The program is a four-year initiative designed to educate neuroimmunology fellows on pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS) — two autoimmune diseases — and how to identify their presence. The program will combine new research and clinical knowledge across disciplines, including otolaryngology, neurology, immunology and neuropathology, to equip future practitioners with the necessary skills to address the disorder effectively. 

PANDAS and PANS are autoimmune diseases that follow an infection — most commonly a streptococcal infection — where the immune system attacks the body’s healthy brain cells, affecting central nervous system function. Despite their serious effects — including changes in personality, development of obsessive-compulsive disorder (OCD), anxiety, tics and in certain cases death — PANDAS and PANS often go unrecognized by health care providers due to the limited available research.

ELIZA MINEAUX/THE HOYA | The Georgetown University Medical Center and the Alex Manfull Fund, announced the launch of a new Fellowship Fund to study PANDAS/PANS, two autoimmune diseases.

Susan Manfull, co-founder and executive director of the Alex Manfull Fund, said the new program promises new discoveries.

“PANDAS/PANS is a multidisciplinary disorder and there are multiple systems involved in producing the symptoms that we see,” Manfull told The Hoya. “The fellowship fund is intended to set the stage for neurology students to work with other disciplines and develop cross-discipline relationships.”

Dr. Carlo Tornatore, the regional chief of neurology for Georgetown MedStar Health, said the program will better equip future healthcare professionals.

“The idea of the fellowship is training out the next generation of doctors who can think about the future,” Tornatore told The Hoya.

Daniela Sosa-Sarkar, board president of the Alex Manfull Fund, said PANDAS and PANS represent challenges in health care disparities with lack of insurance coverage. 

“Insurance coverage is a huge problem for those suffering from PANDAS/PANS, which results at best in delayed treatment and at worst, lack of treatment and the devastating consequences that result,” Sosa-Sarkar told The Hoya. “The health inequities that result from lack of insurance coverage are real and devastating.” 

Tornatore said he is optimistic about potential new discoveries the research will generate as well as its intersection with new technologies. 

“I think we will make unexpected findings as we go along because we’re open,” Tornatore said. “I think over the next decade, we’re going to learn so much, especially with genomics, and AI is really going to explode how we understand.”

Manfull said further research into PANDAS and PANS is crucial for increasing awareness of the conditions among health care professionals and policymakers.

“If we can provide support to increase research, that research can compel doctors and insurance companies to understand that it is a truly serious disorder,” Manfull added.

The Alex Manfull Fund established Georgetown’s POND Brain Bank, the nation’s only brain bank which stores brains from individuals diagnosed with PANDAS, PANS and other neuroimmune disorders. The bank provides detailed neuropathological evaluations and oversees the procurement, storage and distribution of tissue and biofluids to researchers worldwide to discover biomarkers for PANDAS and PANS. 

Sosa-Sarkar said Georgetown has been instrumental in helping study PANDAS, PANS and other diseases.

“Georgetown University has been an invaluable ally to the PANDAS/PANS community,” Sosa-Sarkar said. “Since the creation of the POND Bank, through the support of TAMF, and now The Alex Manfull PANDAS/PANS Fellowship Fund, Georgetown Medical Center has shown its commitment to advancing education and research on PANDAS/PANS.” 

Manfull said the fund’s strength comes from its comprehensive approach to studying the disorder, promoting collaboration across medical departments and examining its various manifestations.

“Establishing The Alex Manfull PANDAS/PANS Fellowship Fund is truly visionary and demonstrates that the Department of Neurology at Georgetown embraces this new frontier in medicine,” Manfull said. 

Lighting Up for PANDAS/PANS

Community News
Published October 22, 2024

PORTSMOUTH — If you happened to cross over or view the World War I Memorial Bridge connecting Portsmouth and Kittery last week, you might have noticed that all of the bright lights had turned green.  Over 200 bridges and landmarks around the world also turned green or red to shed light on PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) and a subcategory of PANS known as PANDAS (Pediatric Autoimmune Neuropsychiatric Disorder w/Streptococcal Infections) Wednesday night.

PANS and PANDAS are such rare conditions that their symptoms are often overlooked or not properly interpreted by physicians and other practitioners.  PANS can occur after a common infection that, in a small number of people, causes the body’s autoimmune system to mistakenly turn on the central nervous system.  Sudden changes to a child’s personality can occur including obsessive-compulsive behaviors, anxiety, tics, abnormal movements, compromises to math and handwriting abilities, sensory sensitivities, restrictive eating, sleep disturbances and more.  The PANDAS, a subcategory of PANS is triggered by a strep infection.  Complex neurological and neuropsychiatric abnormalities subsequently ensue. 

Susan and Towny Manfull of Portsmouth lost their 26 year-old daughter Alex Manfull to PANDAS.

Locally, The Alex Manfull Fund seeks to drive increased awareness of these frightening conditions for the public and for medical practitioners who may encounter such rare and complex symptomologies.  Susan and Towny Manfull of Portsmouth lost their 26-year-old daughter to PANDAS.  Alex was a prolific artist in her preteen years, an accomplished scholar and graduate of Phillips Exeter Academy and Princeton.  She made her young mark on Wall Street before pushing on to challenge Washington, D.C.  Her life was full and full of many friends she met along the way.  Despite all appearances, Alex’s achievements in life were being sadly undermined by PANDAS.  Since her passing in 2018, Susan and Towny have been driven to make certain that other parents don’t share their tragedy.  They have worked with local and national specialists who are keen on further understanding PANDAS and PANS, including the use of brain tissue from the POND Brain Bank at Georgetown University, a brain repository established when the Manfull’s donated their daughter’s brain.  They started the Alex Manfull Fund.  They have stocked their board with doctors and researchers knowledgeable in this highly specialized arena, and they have sought to attract supporters who know how to make a difference in the Seacoast community.

Among those supporters is Gov. Chris Sununu, who proclaimed that for New Hampshire Oct. 9 is a day where “it is imperative that there be a greater public awareness of this health issue, and more must be done to increase activity at the local, state, and national levels so that children can be more quickly diagnosed and treated.”  A gathering of local supporters at the foot of the WWI Memorial Bridge Wednesday included Reverend Robert Thompson who addressed the crowd. Alex Manfull Fund board member Nancy Dougherty who is a Portsmouth-based Lyme disease specialist affiliated with Johns Hopkins Medical School also shared some of her knowledge of autoimmune afflictions with the vested concerned audience.  Portsmouth City Councilors John Tabor and Kate Cook were on hand to lend personal support and that of their families.  There was a heartfelt rendition of the national anthem led by Guilded Age and CODA actress Kayla Caulfield.  Tears of joy were shed as the entire audience spontaneously joined Kayla.

Next up, The Alex Manfull Fund will be hosting its 2024 PANDA/PANS Symposium on Saturday, Nov. 2 at St. John’s Episcopal Church, 100 Chapel St. in Portsmouth from 9 a.m. to 5:30 p.m.  This symposium is for physicians, psychologists, nurses and other health practitioners to advance the understanding and treatment of neuroimmune psychiatric disorders such as PANDAS and PANS.

Radio Interview with Dr. Kyle Williams and Susan Manfull, PhD on WSCA’s Seacoast Currents

Dr. Kyle Williams, a psychiatrist who specializes in OCD and PANDAS/PANS at Mass General Hospital in Boston, was in Portsmouth as a presenter for the November 2nd, 2024 PANDAS/PANS Symposium hosted by The Alex Manfull Fund.

Dr. Williams joined Susan Manfull, PhD at the WSCA FM Radio Station for what was an excellent interview with Kathy Somssich and Larry Drake.

A very informative must-listen-to for all followers of The Alex Manfull Fund.

Head of the Charles entry came together to honor late Phillips Exeter coxswain

The Directors’ Challenge entry, assembled from around the country, rowed together in memory Alex Manfull and to help raise awareness of PANDAS/PANS.

By Hayden Bird

October 24, 2023

In the final race of the 2023 Head of the Charles Regatta, one particular entry in the Directors’ Challenge Mixed Eight was comprised of a group that was rowing together for the very first time.

They represented different rowing backgrounds — including alumni from Phillips Exeter Academy, Princeton University, and members of the Boston Rowing Club — and were assembled from all over the United States.

Their unifying purpose, beyond pulling together in the race, was to honor the memory of a friend.

Alex Manfull, a New Hampshire native, was just 26 when she died in 2018 from complications of an autoimmune disorder called PANDAS (Pediatric AutoImmune Neuropsychiatric Disorders Associated with Streptococcal Infections). It is placed under the overarching category of PANS (Pediatric Acute Onset Neuropsychiatric Syndrome).

Manfull had attended Phillips Exeter, where she first discovered her talent as a coxswain with the crew program.

“She took to it like a fish to water, and loved it, loved being a coxswain,” recalled her mother, Susan.

Manfull went on to attend Princeton, where she coxed for the men’s varsity lightweight crew.

“She was very assertive and driven and focused both in crew and outside of that,” recalled Andrew Wenstein, who rowed in boats that Manfull was coxswain for at both Phillips Exeter and Princeton.

“She was very good at just getting people to kind of trust her and listen to her,” he said.

“Alex was vibrant, healthy, had no history of psychiatric illness,” her mother recalled. “She was healthy in general, confident, smart, all the qualities that one would aspire to have.”

At the age of 19, she was diagnosed with streptococcus. Soon after being treated, she developed “unambiguous OCD symptoms.”

For years afterward, Manfull sought a clearer medical explanation of what was happening to her, but the exact nature of her condition remained unclear. It wasn’t until she came upon a description of PANDAS that she began to unravel the mystery herself.

Even then, Manfull did not receive a formal diagnosis until several weeks before her death.

“The lack of knowledgeable physicians or other medical providers and mental health providers is a huge obstacle because the disorder is not usually recognized,” Susan explained. “It’s frequently misdiagnosed as OCD, or ADHD. And when that happens, of course they don’t get the treatment that they should.”

Given that PANDAS wasn’t first identified until 1998 (in a study from Dr. Susan Swedo), the problem of misdiagnoses remains intrinsically connected with a lack of awareness.

As a result, Manfull’s parents established The Alex Manfull Fund to help support research, treatment, and to elevate public knowledge about its identifiable symptoms.

In the ongoing effort to raise awareness, they decided that assembling a representative entry at this year’s Head of Charles was a way to achieve that goal at an event their daughter loved.

Testament to her spirit, current and former rowers from around the country answered the call.

“We started thinking about doing this about a year and a half ago, and it took a while to kind of figure out all of the logistics and pull it together,” said Wenstein. “She was on teams at Exeter and at Princeton and at Boston Rowing Club in the summer in between. So it felt like we should have people from a few different areas of the rowing world.”

The final result was a respectable 14th place among the 31 Directors’ Challenge entries. Considering their lack of preparation, it was a job well done. And of infinitely greater importance, the Manfull Fund, both through its participation in the race as well as a tent at Reunion Village, was able to help share information about PANDAS/PANS and provide access to experts.

‘Let me die’: the mysterious syndrome changing children overnight

Doctors are uniting to find a cure for Pandas, a disorder that arrives ‘like the flick of a switch’ and torments children as young as three

Louise Eccles | Sunday May 05 2024, 12.01am BST, The Sunday Times

Oliver spent his 14th birthday last month alone in his bedroom, as he has done for the past four years. He did not unwrap a single present and ate his special birthday food alone in the kitchen, late at night, when he knew his mother and sister would be upstairs.

Until the age of nine, he was a sociable, high-achieving boy who was head of his school council. His Year 5 report described him as a popular member of the class and a dedicated learner.

In January 2020, however, he returned home from primary school unusually quiet and withdrawn. When his mother, Megan, checked on him in his bedroom that night, she said it was “literally like a switch had been flipped”.

“He had stripped down to his shorts and he was just rocking in the middle of the room with a fan on him, in the middle of winter, with the window open. He was wailing and saying his skin was hot. He was petrified of falling asleep. He went psychotic overnight.”

Oliver still cannot bear any form of human contact, or even face-to-face conversations. He communicates from the top of the staircase. He has not left the house for two years, since his last hospital admission, and wears no clothes except a blanket.

Having baffled medical professionals for 18 months, Oliver was eventually given a diagnosis of paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, or Pandas, by a neurologist at Birmingham Children’s Hospital.

Hope of treatment

Pandas specifically refers to children who have developed symptoms after contracting streptococcus, which can manifest as scarlet fever, tonsillitis and other conditions.

The charity Pans Pandas UK believes thousands of children could be affected nationwide, but no official figures are collated. Pans refers to the broader condition that can be triggered by other causes.

Professor Rajat Gupta, the consultant paediatric neurologist at Birmingham Children’s Hospital who diagnosed Oliver’s condition in October 2021, said he had diagnosed Pans or Pandas in approximately 100 children. He called for the medical profession to keep an open mind. “Children presenting like this may have a cause which could be easily treated with a short course of antibiotics of two weeks,” he said.

A working group of neurologists, immunologists and paediatricians has been formed to try to come to a national consensus on how to diagnose and treat Pandas, including whether antibiotics or anti-inflammatory drugs should be prescribed alongside psychiatric help.

Conclusions reached by the group will be presented to the National Institute for Health and Care Excellence (Nice), which advises the NHS on best practice. The group includes representatives from the Royal College of Psychiatrists, the Royal College of Paediatrics and Child Health, the Royal College of Nursing and the Royal College of Occupational Therapists.

‘She was clawing at her mum and screaming’

The parents of a schoolgirl who suffered a sudden mental breakdown in November 2021 credited the quick action of a GP for their daughter’s return to health.

Ellie, 13, had been poorly with a sore throat, like several of her friends, but her parents treated her with Calpol and assumed she had recovered.

Her father, Nick, the director of a design company, said: “She left for school in the morning a confident, well-adjusted girl with a great friendship group, and when she returned from school she was experiencing a full panic attack. She was clawing at her mum and screaming, ‘Make it stop’.

“It emerged she was having intrusive thoughts that she might harm herself. She was scared she was going to go into the kitchen drawer and pick up a knife and plunge it into her chest.”

Over the next few days, Ellie developed a tic where she would clear her throat constantly. “She hardly slept because she was worried she would harm herself,” Nick said. “Her age seemed to regress and she played almost toddler-level games with cars. Her pupils were so dilated they were like Disney eyes.”

Nick found the Pans Pandas UK charity website and read about children taking antibiotics to treat an underlying infection.

“We went to the locum GP and she hadn’t heard of Pandas, but she was open-minded. She said, ‘well, I see no issue with trialling a couple of weeks worth of antibiotics while we set up blood tests and refer you to the local hospital’. Within three days the symptoms went from 100 per cent to 25 per cent.”

After Ellie tested positive for historic streptococcus, the same GP prescribed three months of antibiotics. Cognitive behaviour therapy helped to deal with the residual intrusive thoughts and she has now fully recovered.

Self-teaching at home

Unlike many other mental health conditions, Pandas — a term coined in the United States in 1998 — has been linked to unusual symptoms including urinary issues, dramatic loss of skills such as handwriting and unexpected development of special educational needs.

Oliver’s father, Ben, a financial adviser, said. “I remember him just howling like a wild animal in the back of the car and he tried to jump out. He was screaming, ‘Let me die, let me die’.” He was initially diagnosed with an autistic breakdown and treated with anti-psychotic drugs.

Months later, after his mother stumbled across Pandas while researching his condition and raised it with a psychiatrist, Oliver was referred to a neurologist.

Since then he has been prescribed a combination of antibiotics, anti-inflammatory drugs and therapy. Today, he is enrolled at a school that he has never attended. Megan said staff visited regularly but were “at a loss” about what to do. Oliver teaches himself subjects such as politics and history from his bedroom.

Megan said: “He’s starting to come out of it. He even talks about the fact that it’s going to be over at some point, so I think he’s coming back into the world.”

No concrete signs

Dr Ming Lim, a consultant paediatric neurologist at Evelina London Children’s Hospital, who sits on the new working group, said one of the reasons Pandas was controversial was because there was no concrete biomarker, such as a brain scan or blood test, to confirm someone had the condition.

“This is a very peculiar, very recognisable, acute-onset neuropsychiatric syndrome. What I don’t know is why [it occurs], biologically. There is some research into brain inflammation going on.”

Fulvio D’Acquisto, professor of immunology at the University of Roehampton, said Pandas may be caused by an overactive immune response leading to the accumulation in the brain of a protein called Immuno-moodulin. He has an antibody in development that he says could block the protein.

A spokesman for Nice said: “As an organisation, we do not have sufficient resources to create evidence-based guidance for all topics in health and care, and an element of selection is therefore required.” NHS England said it welcomed the work that Pans Pandas UK was conducting with professional bodies to advance research.

The names of all children and parents have been changed